본문 바로가기
KERD
논문KCI 등재

대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제2장 갑상선분화암의 적절한 초기 수술 2024

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 2. Surgical Management of Thyroid Cancer 2024

김정한|김선욱|이민경|박영주|이은경|김희경|이지예|이준협|나동규|정윤재|임재열|송영신|윤지희|임동준|강호철|구본석|김원웅|박준욱|정찬권|유창환|우승훈|이초록|권형주|원호륜|백교림|조윤영
대한갑상선학회 (Korean Thyroid Association)|2024.05|International Journal of Thyroidology|제17권 제1호|pp. 30-52

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

GuidelineSurgery갑상선암Thyroid cancer수술Thyroidectomy갑상선절제술진료권고안대한갑상선학회Korean Thyroid Association
주제분류의학일반

초록

The primary objective of initial treatment for thyroid cancer is minimizing treatment-related side effects and unnecessary interventions while improving patients’ overall and disease-specific survival rates, reducing the risk of disease persistence or recurrence, and conducting accurate staging and recurrence risk analysis. Appropriate surgical treatment is the most important requirement for this purpose, and additional treatments including radioactive iodine therapy and thyroid-stimulating hormone suppression therapy are performed depending on the patients’ staging and recurrence risk. Diagnostic surgery may be considered when repeated pathologic tests yield nondiagnostic results (Bethesda category 1) or atypia of unknown significance (Bethesda category 3), depending on clinical risk factors, nodule size, ultrasound findings, and patient preference. If a follicular neoplasm (Bethesda category 4) is diagnosed pathologically, surgery is the preferred option. For suspicious papillary carcinoma (suspicious for malignancy, Bethesda category 5), surgery is considered similar to a diagnosis of malignancy (Bethesda category 6). As for the extent of surgery, if the cancer is ≤1 cm in size and clinically free of extrathyroidal extension (ETE) (cT1a), without evidence of cervical lymph node (LN) metastasis (cN0), and without obvious reason to resect the contralateral lobe, a lobectomy can be performed. If the cancer is 1-2 cm in size, clinically free of ETE (cT1b), and without evidence of cervical LN metastasis (cN0), lobectomy is the preferred option. For patients with clinically evident ETE to major organs (cT4) or with cervical LN metastasis (cN1) or distant metastasis (M1), regardless of the cancer size, total thyroidectomy and complete cancer removal should be performed at the time of initial surgery. Active surveillance may be considered for adult patients diagnosed with low-risk thyroid papillary microcarcinoma. Endoscopic and robotic thyroidectomy may be performed for low-risk differentiated thyroid cancer when indicated, based on patient preference.

Abstract

The primary objective of initial treatment for thyroid cancer is minimizing treatment-related side effects and unnecessary interventions while improving patients’ overall and disease-specific survival rates, reducing the risk of disease persistence or recurrence, and conducting accurate staging and recurrence risk analysis. Appropriate surgical treatment is the most important requirement for this purpose, and additional treatments including radioactive iodine therapy and thyroid-stimulating hormone suppression therapy are performed depending on the patients’ staging and recurrence risk. Diagnostic surgery may be considered when repeated pathologic tests yield nondiagnostic results (Bethesda category 1) or atypia of unknown significance (Bethesda category 3), depending on clinical risk factors, nodule size, ultrasound findings, and patient preference. If a follicular neoplasm (Bethesda category 4) is diagnosed pathologically, surgery is the preferred option. For suspicious papillary carcinoma (suspicious for malignancy, Bethesda category 5), surgery is considered similar to a diagnosis of malignancy (Bethesda category 6). As for the extent of surgery, if the cancer is ≤1 cm in size and clinically free of extrathyroidal extension (ETE) (cT1a), without evidence of cervical lymph node (LN) metastasis (cN0), and without obvious reason to resect the contralateral lobe, a lobectomy can be performed. If the cancer is 1-2 cm in size, clinically free of ETE (cT1b), and without evidence of cervical LN metastasis (cN0), lobectomy is the preferred option. For patients with clinically evident ETE to major organs (cT4) or with cervical LN metastasis (cN1) or distant metastasis (M1), regardless of the cancer size, total thyroidectomy and complete cancer removal should be performed at the time of initial surgery. Active surveillance may be considered for adult patients diagnosed with low-risk thyroid papillary microcarcinoma. Endoscopic and robotic thyroidectomy may be performed for low-risk differentiated thyroid cancer when indicated, based on patient preference.

참고문헌 (170)

  1. Huang H, "Isthmectomy is effective and sufficient for selected patients with the isthmus-confined solitary papillary thyroid carcinoma", Asian J Surg, 45(9), pp.1678~1681 (2022)
  2. Park H, "Isthmusectomy in selected patients with well-differentiated thyroid carcinoma", Head Neck, 42(1), pp.43~49 (2020)
  3. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", Thyroid, 33(9), pp.1039~1044 (2023)
  4. Kim K, "Diagnostic performance of thyroid core needle biopsy using the revised reporting system : comparison with fine needle aspiration cytology", Endocrinol Metab(Seoul), 37(1), pp.159~169 (2022)
  5. Chung SR, "Risk of malignancy according to the subclassification of atypia of undetermined significance and suspicious follicular neoplasm categories in thyroid core needle biopsies", Endocr Pathol, 30(2), pp.146~154 (2019)
  6. Na HY, "Preoperative diagnostic categories of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in thyroid core needle biopsy and its impact on risk of malignancy", Endocr Pathol, 30(4), pp.329~339 (2019)
  7. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", J Am Soc Cytopathol, 12(5), pp.319~325 (2023)
  8. Jung CK, "2019 practice guidelines for thyroid core needle biopsy : a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association", J Pathol Transl Med, 54(1), pp.64~86 (2020)
  9. Park JY, "Diagnostic efficacy, performance and safety of side-cut core needle biopsy for thyroid nodules : comparison of automated and semi-automated biopsy needles", Endocrine, 76(2), pp.341~348 (2022)
  10. Ahn HS, "Diagnostic performance of core needle biopsy as a first-line diagnostic tool for thyroid nodules according to ultrasound patterns : comparison with fine needle aspiration using propensity score matching analysis", Clin Endocrinol(Oxf), 94(3), pp.494~503 (2021)
  11. Xiong Y, "Pathological diagnosis of thyroid nodules based on core needle biopsies : comparative study between core needle biopsies and resected specimens in 578 cases", Diagn Pathol, 14(1), pp.10~ (2019)
  12. Ahn HS, "Comparison of the diagnostic efficacy of ultrasound-guided core needle biopsy with 18-versus 20-gauge needles for thyroid nodules", J Ultrasound Med, 37(11), pp.2565~2574 (2018)
  13. Choe J, "Core needle biopsy of thyroid nodules : outcomes and safety from a large single-center single-operator study", Acta Radiol, 59(8), pp.924~931 (2018)
  14. Hong MJ, "Role of core needle biopsy as a first-line diagnostic tool for thyroid nodules : a retrospective cohort study", Ultrasonography, 37(3), pp.244~253 (2018)
  15. Kim HC, "First-line use of core needle biopsy for high-yield preliminary diagnosis of thyroid nodules", AJNR Am J Neuroradiol, 38(2), pp.357~363 (2017)
  16. Suh CH, "Efficacy and safety of core-needle biopsy in initially detected thyroid nodules via propensity score analysis", Sci Rep, 7(1), pp.8242~ (2017)
  17. Suh CH, "The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules", Thyroid, 26(3), pp.395~403 (2016)
  18. Kim YH, "Applying ultrasound-guided core needle biopsy for diagnosis of thyroid masses : preliminary results from a single institution", J Ultrasound Med, 34(10), pp.1801~1808 (2015)
  19. Ha EJ, "Core needle biopsy can minimise the non-diagnostic results and need for diagnostic surgery in patients with calcified thyroid nodules", Eur Radiol, 24(6), pp.1403~1409 (2014)
  20. Ha EJ, "Sonographically suspicious thyroid nodules with initially benign cytologic results : the role of a core needle biopsy", Thyroid, 23(6), pp.703~708 (2013)
  21. Sung JY, "Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort", Eur Radiol, 22(7), pp.1564~1572 (2012)
  22. Joo L, "Comparison of core needle biopsy and repeat fine-needle aspiration in avoiding diagnostic surgery for thyroid nodules initially diagnosed as atypia", follicular lesion of undetermined significance, 2022, pp.23(2), 280~288
  23. Choe JY, "Utility of a formatted pathologic reporting system in thyroid core needle biopsy : a validation study of 1998 consecutive cases", Clin Endocrinol(Oxf), 88(1), pp.96~104 (2018)
  24. Hauch A, "Total thyroidectomy is associated with increased risk of complications for low-and high-volume surgeons", Ann Surg Oncol, 21(12), pp.3844~3852 (2014)
  25. Park I, "Preserving parathyroid gland vasculature to reduce postthyroidectomy hypocalcemia", World J Surg, 40(6), pp.1382~1389 (2016)
  26. Park S, "Clinical features of early and late postoperative hypothyroidism after lobectomy", J Clin Endocrinol Metab, 102(4), pp.1317~1324 (2017)
  27. Vuong HG, "The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules : a metaanalysis", Thyroid, 31(8), pp.1203~1211 (2021)
  28. Lee YB, "Comparison of four ultrasonography-based risk stratification systems in thyroid nodules with nondiagnostic", unsatisfactory cytology : a real-world study, 2021, pp.13(8), 1948~
  29. Hong MJ, "Cytology-ultrasonography risk-stratification scoring system based on fine-needle aspiration cytology and the Korean-Thyroid Imaging Reporting and Data System", Thyroid, 27(7), pp.953~959 (2017)
  30. Vuong HG, "Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries : a systematic review and meta-analysis", Cancer Cytopathol, 128(4), pp.238~249 (2020)
  31. Ngo HTT, "Impact of molecular testing on the management of indeterminate thyroid nodules among Western and Asian countries : a systematic review and meta-analysis", Endocr Pathol, 32(2), pp.269~279 (2021)
  32. Słowińska-Klencka D, "Diagnostic value of six Thyroid Imaging Reporting and Data Systems(TIRADS)in cytologically equivocal thyroid nodules", J Clin Med, 9(7), pp.2281~ (2020)
  33. Hong HS, "Diagnostic performance of ultrasound patterns by K-TIRADS and 2015 ATA guidelines in risk stratification of thyroid nodules and follicular lesions of undetermined significance", AJR Am J Roentgenol, 213(2), pp.444~450 (2019)
  34. Nikiforov YE, "Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma : a paradigm shift to reduce overtreatment of indolent tumors", JAMA Oncol, 2(8), pp.1023~1029 (2016)
  35. Cho YY, "Malignancy risk of follicular neoplasm(Bethesda IV)with variable cutoffs of tumor size : a systemic review and meta-analysis", J Clin Endocrinol Metab, 109(5), pp.1383~1392 (2024)
  36. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
  37. Durante C, "2023 European Thyroid Association clinical practice guidelines for thyroid nodule management", Eur Thyroid J, 12(5), pp.e230067~ (2023)
  38. Agarwal S, "Emerging biomarkers in thyroid practice and research", Cancers(Basel), 14(1), pp.204~ (2021)
  39. Lasolle H, "SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules : role of molecular tests for cytologically indeterminate thyroid nodules", Ann Endocrinol(Paris), 83(6), pp.395~400 (2022)
  40. Trimboli P, "Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy(TIR4)or malignant(TIR5)according to Italian classification system : a systematic review and meta-analysis", Endocrine, 78(1), pp.24~31 (2022)
  41. Chen B, "The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma : a systematic review and meta-analysis", Clin Endocrinol(Oxf), 94(5), pp.731~742 (2021)
  42. Moon S, "Effects of coexistent BRAF(V600E)and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer : a meta-analysis", Thyroid, 27(5), pp.651~660 (2017)
  43. Zhang C, "Total thyroidectomy versus lobectomy for papillary thyroid cancer : a systematic review and meta-analysis", Medicine(Baltimore), 99(6), pp.e19073~ (2020)
  44. Macedo FI, "Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma : a meta-analysis", Surg Oncol, 24(2), pp.117~122 (2015)
  45. Bilimoria KY, "Extent of surgery affects survival for papillary thyroid cancer", Ann Surg, 246(3), pp.375~381 (2007)
  46. Rajjoub SR, "Thyroid lobectomy is not sufficient for T2papillary thyroid cancers", Surgery, 163(5), pp.1134~1143 (2018)
  47. Suman P, "Thyroid lobectomy for T1b-T2 papillary thyroid cancer with high-risk features", J Am Coll Surg, 230(1), pp.136~144 (2020)
  48. Nixon IJ, "An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC", UICC staging system for well-differentiated thyroid cancer, 2016, pp.26(3), 373~380
  49. Capezzone M, "Familial non-medullary thyroid cancer : a critical review", J Endocrinol Invest, 44(5), pp.943~950 (2021)
  50. Saenko V, "Radiation-related thyroid cancer", Endocr Rev, 45(1), pp.1~29 (2024)
  51. Adam MA, "Extent of surgery for papillary thyroid cancer is not associated with survival : an analysis of 61, 775 patients", Ann Surg, 260(4), pp.601~605 (2014)
  52. Tuttle RM, "Updated American Joint Committee on cancer", tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer(eighth edition) : what changed and why?, 2017, pp.27(6), 751~756
  53. Kim TH, "Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma", Oral Oncol, 71, pp.81~86 (2017)
  54. Tam S, "Survival in differentiated thyroid cancer : comparing the AJCC cancer staging seventh and eighth editions", Thyroid, 28(10), pp.1301~1310 (2018)
  55. Xiang J, "The new T3b category has clinical significance? SEER-based study", Clin Endocrinol (Oxf), 94(3), pp.449~459 (2021)
  56. Park SY, "Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma", Br J Surg, 105(9), pp.1155~1162 (2018)
  57. Song E, "A relook at the T stage of differentiated thyroid carcinoma with a focus on gross extrathyroidal extension", Thyroid, 29(2), pp.202~208 (2019)
  58. Park JO, "Guideline for the surgical management of locally invasive differentiated thyroid cancer from the Korean Society of Head and Neck Surgery", Clin Exp Otorhinolaryngol, 16(1), pp.1~19 (2023)
  59. Lee DY, "Comparison of learning curves for retroauricular and transaxillary endoscopic hemithyroidectomy", Ann Surg Oncol, 23(12), pp.4023~4028 (2016)
  60. Lee J, "The learning curve for robotic thyroidectomy : a multicenter study", Ann Surg Oncol, 18(1), pp.226~232 (2011)
  61. Adam MA, "Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes?", Ann Surg, 265(2), pp.402~407 (2017)
  62. Ito Y, "An observational trial for papillary thyroid microcarcinoma in Japanese patients", World J Surg, 34(1), pp.28~35 (2010)
  63. Molinaro E, "Active surveillance in papillary thyroid microcarcinomas is feasible and safe : experience at a single Italian center", J Clin Endocrinol Metab, 105(3), pp.e172~e180 (2020)
  64. Sanabria A, "Experience with active surveillance of thyroid low-risk carcinoma in a developing country", Thyroid, 30(7), pp.985~991 (2020)
  65. Jin M, "Tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma : a multicenter cohort study in Korea", Thyroid, 31(10), pp.1494~1501 (2021)
  66. Nagaoka R, "Multifocality and progression of papillary thyroid microcarcinoma during active surveillance", World J Surg, 45(9), pp.2769~2776 (2021)
  67. Ho AS, "Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma : a nonrandomized controlled trial", JAMA Oncol, 8(11), pp.1588~1596 (2022)
  68. Lee EK, "Progression of low-risk papillary thyroid microcarcinoma during active surveillance : interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea", Thyroid, 32(11), pp.1328~1336 (2022)
  69. Ito Y, "Thyroid-stimulating hormone, age, and tumor size are risk factors for progression during active surveillance of low-risk papillary thyroid microcarcinoma in adults", World J Surg, 47(2), pp.392~401 (2023)
  70. Miyauchi A, "Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma : 30-year experience", Thyroid, 33(7), pp.817~825 (2023)
  71. Tuttle RM, "Active surveillance of papillary thyroid cancer : frequency and time course of the six most common tumor volume kinetic patterns", Thyroid, 32(11), pp.1337~1345 (2022)
  72. Oh HS, "Tumor volume doubling time in active surveillance of papillary thyroid carcinoma", Thyroid, 29(5), pp.642~649 (2019)
  73. Lee JY, "US predictors of papillary thyroid microcarcinoma progression at active surveillance", Radiology, 309(1), pp.e230006~ (2023)
  74. Ito Y, "Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation", Thyroid, 24(1), pp.27~34 (2014)
  75. Mazzaferri EL, "Approach to the pregnant patient with thyroid cancer", J Clin Endocrinol Metab, 96(2), pp.265~272 (2011)
  76. Oh HS, "Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy", Thyroid, 27(6), pp.773~777 (2017)
  77. Ito Y, "Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital", Thyroid, 26(1), pp.156~160 (2016)
  78. Horiguchi K, "Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma(T1aN0M0)in adults", Endocr J, 68(7), pp.763~780 (2021)
  79. Hwang H, "Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from MAeSTro study : immediate operation versus delayed operation after active surveillance. A multicenter prospective cohort study", Ann Surg, 278(5), pp.e1087~e1095 (2023)
  80. Kim K, "Active surveillance versus immediate surgery for low-risk papillary thyroid microcarcinoma patients in South Korea : a cost-minimization analysis from the MAeSTro study", Thyroid, 32(6), pp.648~656 (2022)
  81. Baek HS, "Cost-effectiveness of active surveillance compared to early surgery of small papillary thyroid cancer : a retrospective study on a Korean population", J Korean Med Sci, 38(34), pp.e264~ (2023)
  82. Kong SH, "Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients : active surveillance or immediate surgery(interim analysis of MAeSTro)", Thyroid, 29(8), pp.1089~1096 (2019)
  83. Moon JH, "Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma", J Clin Endocrinol Metab, 106(3), pp.724~735 (2021)
  84. Hwangbo Y, "A cross-sectional survey of patient treatment choice in a multicenter prospective cohort study on active surveillance of papillary thyroid microcarcinoma(MAeSTro)", Thyroid, 32(7), pp.772~780 (2022)
  85. Brito JP, "Thyroid cancer treatment choice : a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options", Thyroid, 28(10), pp.1325~1331 (2018)
  86. Issa PP, "Radiologist versus non-radiologist detection of lymph node metastasis in papillary thyroid carcinoma by ultrasound : a meta-analysis", Biomedicines, 10(10), pp.2575~ (2022)
  87. Suh CH, "Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer : a systematic review and meta-analysis", AJNR Am J Neuroradiol, 38(1), pp.154~161 (2017)
  88. Lee DH, "Computed tomography for detecting cervical lymph node metastasis in patients who have papillary thyroid microcarcinoma with tumor characteristics appropriate for active surveillance", Thyroid, 29(11), pp.1653~1659 (2019)
  89. Xing Z, "Thyroid cancer neck lymph nodes metastasis : meta-analysis of US and CT diagnosis", Eur J Radiol, 129, pp.109103~ (2020)
  90. Gronlund MP, "Risk factors for recurrence of follicular thyroid cancer : a systematic review", Thyroid, 31(10), pp.1523~1530 (2021)
  91. Kim BY, "Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma", Eur Arch Otorhinolaryngol, 277(2), pp.569~576 (2020)
  92. Ito Y, "Excellent prognosis of central lymph node recurrence-free survival for cN0M0 papillary thyroid carcinoma patients who underwent routine prophylactic central node dissection", World J Surg, 42(8), pp.2462~2468 (2018)
  93. Kim M, "Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma : a multicenter cohort study", Oral Oncol, 87, pp.97~103 (2018)
  94. Ito Y, "The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons : core questions and recommendations for treatments of thyroid cancer", Endocr J, 67(7), pp.669~717 (2020)
  95. Song E, "Clinical significance of gross invasion of strap muscles in patients with 1-to 4-cm-sized papillary thyroid carcinoma undergoing lobectomy", Ann Surg Oncol, 26(13), pp.4466~4471 (2019)
  96. Jang SW, "Recurrence risk evaluation in patients with papillary thyroid carcinoma : multicenter machine learning evaluation of lymph node variables", Cancers(Basel), 15(2), pp.550~ (2023)
  97. Alsubaie KM, "Prophylactic central neck dissection for clinically node-negative papillary thyroid carcinoma", Laryngoscope, 132(6), pp.1320~1328 (2022)
  98. Back K, "Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis", Eur J Surg Oncol, 47(6), pp.1339~1345 (2021)
  99. Viola D, "Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma : clinical implications derived from the first prospective randomized controlled single institution study", J Clin Endocrinol Metab, 100(4), pp.1316~1324 (2015)
  100. Ahn JH, "A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma", Surgery, 171(1), pp.182~189 (2022)
  101. Wang Y, "The effectiveness and safety of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma patients : a meta-analysis", Front Endocrinol(Lausanne), 13, pp.1094012~ (2022)
  102. Sanabria A, "Prophylactic central neck lymph node dissection in low-risk thyroid carcinoma patients does not decrease the incidence of locoregional recurrence : a metaanalysis of randomized trials", Ann Surg, 276(1), pp.66~73 (2022)
  103. Chen L, "Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes : a systematic review and meta-analysis", World J Surg, 42(9), pp.2846~2857 (2018)
  104. Zhao WJ, "Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma : an updated meta-analysis", Eur J Surg Oncol, 43(11), pp.1989~2000 (2017)
  105. Hartl DM, "Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma", World J Surg, 37(8), pp.1951~1958 (2013)
  106. Conzo G, "Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients : a retrospective study of a large clinical series", Surgery, 155(6), pp.998~1005 (2014)
  107. Perros P, "Guidelines for the management of thyroid cancer", Clin Endocrinol (Oxf), 81(Suppl 1), pp.1~122 (2014)
  108. Filetti S, "Thyroid cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up", Ann Oncol, 30(12), pp.1856~1883 (2019)
  109. Haddad RI, "Thyroid carcinoma, version 2. 2022, NCCN Clinical Practice Guidelines in Oncology", J Natl Compr Canc Netw, 20(8), pp.925~951 (2022)
  110. Yan S, "Prophylactic bilateral central neck dissection should be evaluated based on prospective randomized study of 581 PTC patients", BMC Endocr Disord, 22(1), pp.5~ (2022)
  111. Tao Y, "BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer", J Clin Endocrinol Metab, 106(11), pp.3228~3238 (2021)
  112. Zhang Z, "Integrating BRAF(V600E)mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma", BMC Cancer, 22(1), pp.461~ (2022)
  113. Erdem E, "Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma", Eur J Surg Oncol, 29(9), pp.747~749 (2003)
  114. Tan MP, "Impact of timing on completion thyroidectomy for thyroid cancer", Br J Surg, 89(6), pp.802~804 (2002)
  115. Untch BR, "Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma", Ann Surg Oncol, 21(4), pp.1374~1378 (2014)
  116. Li G, "Implications of extrathyroidal extension invading only the strap muscles in papillary thyroid carcinomas", Thyroid, 30(1), pp.57~64 (2020)
  117. Amit M, "Extrathyroidal extension : does strap muscle invasion alone influence recurrence and survival in patients with differentiated thyroid cancer?", Ann Surg Oncol, 25(11), pp.3380~3388 (2018)
  118. Danilovic DLS, "Is there a difference between minimal and gross extension into the strap muscles for the risk of recurrence in papillary thyroid carcinomas?", Thyroid, 30(7), pp.1008~1016 (2020)
  119. Kang IK, "Is completion thyroidectomy necessary in patients with papillary thyroid carcinoma who underwent lobectomy?", Korean J Head Neck Oncol, 37(2), pp.25~31 (2021)
  120. Baloch ZW, "Overview of the 2022 WHO classification of thyroid neoplasms", Endocr Pathol, 33(1), pp.27~63 (2022)
  121. Wreesmann VB, "Prognostic value of vascular invasion in welldifferentiated papillary thyroid carcinoma", Thyroid, 25(5), pp.503~508 (2015)
  122. Suh YJ, "Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery : a retrospective analysis of 3381 patients", Ann Surg Oncol, 22(11), pp.3543~3549 (2015)
  123. de Castro TP, "Predictors for papillary thyroid cancer persistence and recurrence : a retrospective analysis with a 10-year follow-up cohort study", Clin Endocrinol(Oxf), 85(3), pp.466~474 (2016)
  124. Sorrenti S, "Evaluation of clinicopathological and molecular parameters on disease recurrence of papillary thyroid cancer patient : a retrospective observational study", Cancers(Basel), 12(12), pp.3637~ (2020)
  125. Falvo L, "Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma", Ann Surg, 241(4), pp.640~646 (2005)
  126. Furlan JC, "Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas", J Am Coll Surg, 198(3), pp.341~348 (2004)
  127. Cao J, "Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma : a matched-case comparative study", J Clin Pathol, 69(10), pp.872~877 (2016)
  128. Chereau N, "Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?", Langenbecks Arch Surg, 401(2), pp.223~230 (2016)
  129. Gardner RE, "Prognostic importance of vascular invasion in papillary thyroid carcinoma", Arch Otolaryngol Head Neck Surg, 126(3), pp.309~312 (2000)
  130. Akslen LA, "Prognostic importance of various clinicopathological features in papillary thyroid carcinoma", Eur J Cancer, 29A(1), pp.44~51 (1992)
  131. Kang SW, "Robot-assisted endoscopic surgery for thyroid cancer : experience with the first 100 patients", Surg Endosc, 23(11), pp.2399~2406 (2009)
  132. Lee KE, "Endoscopic thyroidectomy with the da Vinci robot system using the bilateral axillary breast approach(BABA)technique : our initial experience", Surg Laparosc Endosc Percutan Tech, 19(3), pp.e71~e75 (2009)
  133. Singer MC, "Robotic facelift thyroidectomy : I. Preclinical simulation and morphometric assessment", Laryngoscope, 121(8), pp.1631~1635 (2011)
  134. Richmon JD, "Transoral robotic-assisted thyroidectomy with central neck dissection : preclinical cadaver feasibility study and proposed surgical technique", J Robot Surg, 5(4), pp.279~282 (2011)
  135. Lang BH, "A systematic review and meta-analysis evaluating completeness and outcomes of robotic thyroidectomy", Laryngoscope, 125(2), pp.509~518 (2015)
  136. Martino B, "Conversion rates in robotic thyroid surgery : a systematic review and meta-analysis", Int J Med Robot, 18(5), pp.e2427~ (2022)
  137. Sun GH, "Systematic review and meta-analysis of robotic vs conventional thyroidectomy approaches for thyroid disease", Otolaryngol Head Neck Surg, 150(4), pp.520~532 (2014)
  138. Pan JH, "Robotic thyroidectomy versus conventional open thyroidectomy for thyroid cancer : a systematic review and meta-analysis", Surg Endosc, 31(10), pp.3985~4001 (2017)
  139. Wang YC, "Robotic thyroidectomy versus conventional open thyroidectomy for differentiated thyroid cancer : meta-analysis", J Laryngol Otol, 129(6), pp.558~567 (2015)
  140. Kihara M, "Outcome of vocal cord function after partial layer resection of the recurrent laryngeal nerve in patients with invasive papillary thyroid cancer", Surgery, 155(1), pp.184~189 (2014)
  141. Moritani S, "Novel surgical methods for reconstruction of the recurrent laryngeal nerve : microscopeguided partial layer resection and intralaryngeal reconstruction of the recurrent laryngeal nerve", Surgery, 169(5), pp.1124~1130 (2021)
  142. Nishida T, "Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer", Ann Surg, 226(1), pp.85~91 (1997)
  143. Kamani D, "Electrophysiologic monitoring characteristics of the recurrent laryngeal nerve preoperatively paralyzed or invaded with malignancy", Otolaryngol Head Neck Surg, 149(5), pp.682~688 (2013)
  144. Kim KH, "Therapeutic dilemmas in the management of thyroid cancer with laryngotracheal involvement", Otolaryngol Head Neck Surg, 122(5), pp.763~767 (2000)
  145. Iwaki S, "Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords", Head Neck, 39(3), pp.427~431 (2017)
  146. Yuan Q, "Selective vagus-recurrent laryngeal nerve anastomosis in thyroidectomy with cancer invasion or iatrogenic transection", Langenbecks Arch Surg, 405(4), pp.461~468 (2020)
  147. Cody HS 3rd, "Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center", Am J Surg, 142(4), pp.480~483 (1981)
  148. Wada N, "Clinical outcome of different modes of resection in papillary thyroid carcinomas with laryngotracheal invasion", Langenbecks Arch Surg, 391(6), pp.545~549 (2006)
  149. Shin DH, "Pathologic staging of papillary carcinoma of the thyroid with airway invasion based on the anatomic manner of extension to the trachea : a clinicopathologic study based on 22 patients who underwent thyroidectomy and airway resection", Hum Pathol, 24(8), pp.866~870 (1993)
  150. McCarty TM, "Surgical management of thyroid cancer invading the airway", Ann Surg Oncol, 4(5), pp.403~408 (1997)
  151. McCaffrey JC, "Aerodigestive tract invasion by well-differentiated thyroid carcinoma : diagnosis, management, prognosis, and biology", Laryngoscope, 116(1), pp.1~11 (2006)
  152. Ito Y, "Local prognosis of patients with papillary thyroid carcinoma who were intra-operatively diagnosed as having minimal invasion of the trachea : a 17-year experience in a single institute", Asian J Surg, 32(2), pp.102~108 (2009)
  153. Su SY, "Well-differentiated thyroid cancer with aerodigestive tract invasion : long-term control and functional outcomes", Head Neck, 38(1), pp.72~78 (2016)
  154. Wang LY, "Operative management of locally advanced, differentiated thyroid cancer", Surgery, 160(3), pp.738~746 (2016)
  155. Matsumoto F, "Surgical management of tracheal invasion by well-differentiated thyroid cancer", Cancers(Basel), 13(4), pp.797~ (2021)
  156. Allen M, "Tracheal resection in the management of thyroid cancer : an evidence-based approach", Laryngoscope, 131(4), pp.932~946 (2021)
  157. Ji YB, "Surgical management of tracheal invasion by differentiated thyroid cancer : how we do it", Clin Otolaryngol, 34(6), pp.565~567 (2009)
  158. Musholt TJ, "Invasive differentiated thyroid carcinoma : tracheal resection and reconstruction procedures in the hands of the endocrine surgeon", Surgery, 126(6), pp.1078~1087 (1999)
  159. Shadmehr MB, "Thyroid cancers with laryngotracheal invasion", Eur J Cardiothorac Surg, 41(3), pp.635~640 (2012)
  160. Park CS, "Cartilage-shaving procedure for the control of tracheal cartilage invasion by thyroid carcinoma", Head Neck, 15(4), pp.289~291 (1993)
  161. Ozaki O, "Surgery for patients with thyroid carcinoma invading the trachea : circumferential sleeve resection followed by end-to-end anastomosis", Surgery, 117(3), pp.268~271 (1995)
  162. Tsai YF, "Aggressive resection of the airway invaded by thyroid carcinoma", Br J Surg, 92(11), pp.1382~1387 (2005)
  163. Tsukahara K, "Surgical management of tracheal shaving for papillary thyroid carcinoma with tracheal invasion", Acta Otolaryngol, 129(12), pp.1498~1502 (2009)
  164. Warshavsky A, "Outcomes of tracheal resections in well-differentiated thyroid cancer-a case series and meta-analysis", World J Surg, 45(9), pp.2752~2758 (2021)
  165. Moritani S, "Window resection for intraluminal cricotracheal invasion by papillary thyroid carcinoma", World J Surg, 41(7), pp.1812~1819 (2017)
  166. Ebihara M, "Window resection of the trachea and secondary reconstruction for invasion by differentiated thyroid carcinoma", Auris Nasus Larynx, 38(2), pp.271~275 (2011)
  167. Brauckhoff M, "Classification of aerodigestive tract invasion from thyroid cancer", Langenbecks Arch Surg, 399(2), pp.209~216 (2014)
  168. McCaffrey TV, "Locally invasive papillary thyroid carcinoma : 1940-1990", Head Neck, 16(2), pp.165~172 (1994)
  169. Nixon IJ, "Management of invasive differentiated thyroid cancer", Thyroid, 26(9), pp.1156~1166 (2016)
  170. Ballantyne AJ, "Resections of the upper aerodigestive tract for locally invasive thyroid cancer", Am J Surg, 168(6), pp.636~639 (1994)

관련 논문AI추천

대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024강호철, 구본석, 권형주, 김근영, 김미진, 김보현, 김선욱, 김원구, 김원배, 김원웅, 김정한, 김희경, 나동규, 나희영, 문신제, 문정은, 박도준, 박소현, 박영주, 박준욱, 방지인, 백교림, 서영덕, 송영신, 신동엽, 신수진, 안화영, 오소원, 우승훈, 원호륜, 유창환, 윤지희, 이가희, 이민경, 이상우, 이승은, 이시훈, 이영아, 이은경, 이준협, 이지예, 이지은, 이초록, 임동준, 임재열, 전윤경, 정경연, 정아리, 정웅윤, 정윤재, 정찬권, 조관훈, 조윤영, 홍아람, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안 2024 어떻게 바뀌었나: 진단부터 초기치료까지이은경대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제2호대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제5장 갑상선분화암의 수술 후 초기 질병 상태와 재발위험도 평가 및 초기위험군 분류 2024강호철, 김선욱, 나동규, 문신제, 박영주, 송영신, 이은경, 임동준, 정경연, 정윤재, 정찬권대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호1-4 cm 갑상선 유두상암의 초기 수술로 엽절제술의적용조진성대한갑상선학회 · International Journal of Thyroidology2021 · 제14권 제2호대한갑상선학회 갑상선분화암 진료권고안; Part III. 진행성 갑상선분화암의 치료 - 제1-2장 갑상선 수술부위 재발 또는 경부 전이림프절에 대한 수술 및 비수술적 치료 2024강호철, 구본석, 권형주, 김선욱, 김원웅, 김정한, 나동규, 박영주, 박준욱, 백교림, 송영신, 우승훈, 원호륜, 유창환, 이민경, 이은경, 이준협, 이지예, 이초록, 임동준, 임재열, 정윤재대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part II. 갑상선분화암의 추적 2024강호철, 김미진, 김보현, 김선욱, 나동규, 박영주, 방지인, 서영덕, 송영신, 오소원, 이민경, 이상우, 이은경, 이지예, 임동준, 정아리, 정윤재, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호

이 간행물의 다른 논문 (16건)

대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024조윤영, 이승은, 박소현, 이상우, 이준협, 이지예, 이지은, 김희경, 이은경, 이민경, 김미진, 김선욱, 김정한, 정경연, 강호철, 임동준, 서영덕, 김원구, 이시훈, 문정은, 신수진, 김원배, 윤지희, 오소원, 송영신, 이가희, 임재열, 전윤경, 신동엽, 정윤재, 나동규, 김근영, 이영아, 김보현, 방지인, 조관훈, 박영주, 홍채문, 문신제, 홍아람, 백교림, 정웅윤, 정아리, 원호륜, 권형주, 나희영, 이초록, 우승훈, 박도준, 유창환, 정찬권, 박준욱, 김원웅, 구본석, 안화영pp. 1-20대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제1장 갑상선분화암의 수술 전 병기를 예측하기 위한 영상 및 혈액 검사 2024김선욱, 이민경, 박영주, 이은경, 이상우, 나동규, 정윤재, 송영신, 임동준, 강호철, 이지예, 조관훈, 방지인pp. 21-29대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제3장 갑상선분화암의 수술 전후 합병증 평가 2024김선욱, 박영주, 이시훈, 유창환, 홍아람, 원호륜, 우승훈, 박준욱, 구본석, 강호철, 임동준, 이은경, 나동규, 정윤재, 전윤경, 임재열, 송영신pp. 53-60대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024김선욱, 신수진, 나희영, 정찬권, 강호철, 임동준, 송영신, 정윤재, 나동규, 이은경, 박영주pp. 61-67대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제5장 갑상선분화암의 수술 후 초기 질병 상태와 재발위험도 평가 및 초기위험군 분류 2024박영주, 김선욱, 이은경, 문신제, 정찬권, 정경연, 강호철, 임동준, 송영신, 정윤재, 나동규pp. 68-96
원문 보기